EHA 2019 | Myelofibrosis: unmet needs

Name: Myelofibrosis: unmet needs
Uploaded: 2019-06-14T00:00:00.000Z
Duration: 1 min 2 s
Description: Kristen Pettit, MD, University of Michigan, Ann Arbor, MI, tells us about the pathology of myelofibrosis, the current FDA approved medication available and the unmet needs patients face. This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

Kristen Pettit • 14 Jun 2019

EHA 2019

Myelofibrosis

Kristen Pettit, MD, University of Michigan, Ann Arbor, MI, tells us about the pathology of myelofibrosis, the current FDA approved medication available and the unmet needs patients face. This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.